Bio Path reported $4K in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
Baxter International USD 10M 4M Sep/2025
Bio Path USD 4K 0 Dec/2024
Compugen USD 954K 116K Sep/2025
CSL USD 18M 1000K Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024